Login
$COGT
$30.91 -$0.30 (0.96%) Close

$COGT 4 SEC Filings

Filed On Filing
05 Oct 2026 Form 4: Ferrante Karen Jean, Director

Granted 759 Stock Option (Right to Buy)

31 Aug 2026 Form 4: Morris Arlene, Director

Received 45,510 shares by exercise or conversion ($245K) · Sold 45,510 shares ($1.69M)

06 Jul 2026 Form 4: Ferrante Karen Jean, Director

Granted 627 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Harwin Peter Evan, Director

Granted 17,901 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Ferrante Karen Jean, Director

Granted 17,901 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Cain Christopher W., Director

Granted 17,901 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Shegog Todd, Director

Granted 17,901 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Morris Arlene, Director

Granted 17,901 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Ros Matthew, Director

Granted 17,901 Stock Option (Right to Buy)

21 May 2026 Form 4: Robbins Andrew R, Director

Gave 160,000 shares as a gift · Acquired 160,000 shares (Gift)

03 Apr 2026 Form 4: Ferrante Karen Jean, Director

Granted 686 Stock Option (Right to Buy)

31 Mar 2026 Form 4: Fairmount Funds Management Llc, Director

Received 7,000,000 shares by conversion · Sold 7,000,000 shares ($243M)

22 Jan 2026 Form 4: Fairmount Funds Management Llc, Director

Sold 3,500,000 shares ($127M)

05 Jan 2026 Form 4: Ferrante Karen Jean, Director

Granted 643 Stock Option (Right to Buy)

30 Dec 2025 Form 4: Kearns Evan, Chief Legal Officer

Sold 65,000 shares ($2.52M)

30 Dec 2025 Form 4: Green John L., Chief Financial Officer

Sold 77,000 shares ($2.98M)

30 Dec 2025 Form 4: Sachs Jessica, Chief Medical Officer

Sold 82,642 shares ($3.2M)

30 Dec 2025 Form 4: Robinson John Edward, Chief Scientific Officer

Sold 90,000 shares ($3.49M)

19 Dec 2025 Form 4: Robinson John Edward, Chief Scientific Officer

Received 370,000 shares as a grant or award · Gave up 139,998 shares to cover exercise price or tax ($5.52M) · Granted 65,000 Stock Option (Right to Buy)

19 Dec 2025 Form 4: Robbins Andrew R, Director

Received 1,025,000 shares as a grant or award · Gave up 367,497 shares to cover exercise price or tax ($14.5M) · Granted 245,000 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support